Answering human papillomavirus vaccine concerns; a matter of science and time

作者：Hawkes David^*; Lea Candice E; Berryman Matthew J

来源：Infectious Agents and Cancer, 2013, 8(1): UNSP 22.

DOI：10.1186/1750-9378-8-22

• Human papillomavirus
• HPV
• Safety
• Cervical cancer
• Cancer prevention
• Adverse events
• Clinical trials

Since the introduction of the HPV vaccine, questions have been asked about its efficacy in preventing cancer linked with HPV. Concerns about the HPV vaccine safety profile have also been raised. This paper highlights the rapidly growing body of evidence (including clinical trials and post-marketing surveillance) illustrating both the safety of the HPV vaccine, through a detailed investigation of reported adverse events, and its efficacy in reducing both HPV infections rates and the resulting drop in cervical lesions, which have been demonstrated to be good predictors of cervical cancer risk.

• 出版日期2013-6-12